---
title: 'Utilization of allogeneic hematopoietic stem cell transplantation among patients
  with newly diagnosed acute myeloid leukemia in California: a population-based linked
  dataset study'
date: '2024-09-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39219504/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240903182030&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: Acute myeloid leukemia (AML) often requires allogeneic hematopoietic
  cell transplantation (alloHCT) for cure, but historically alloHCT has been strikingly
  underutilized. Reasons for this remain uncertain at the population level. We examined
  alloHCT utilization over time and explored associations between demographic/healthcare
  factors and use of alloHCT by age group (AYA 15-39y, adult 40-64y, older adult 65-79y)
  using a linked dataset merging the Center for International Blood and ...
disable_comments: true
---
Acute myeloid leukemia (AML) often requires allogeneic hematopoietic cell transplantation (alloHCT) for cure, but historically alloHCT has been strikingly underutilized. Reasons for this remain uncertain at the population level. We examined alloHCT utilization over time and explored associations between demographic/healthcare factors and use of alloHCT by age group (AYA 15-39y, adult 40-64y, older adult 65-79y) using a linked dataset merging the Center for International Blood and ...